more, larger trials are underway (including tirzepatide)
So its not just about the vaccines, but how do we move forward as a community, as researchers, as patient advocates, as healthcare professionals in providing care to those individuals through either antiviral therapy thats out there, antibody therapy that needs to be out there, and as efficacious if not more than oral antivirals, and how do we ensure that those therapies get to the patients in a timely manner
Acknowledgements The authors benefited greatly from the advice of Jesse Gregory, III, University of Florida, Barry Shane, University of California, Berkeley, and Marian Neuhouser, Fred Hutchinson Cancer Research Center
SkM was collected after euthanasia, cut into 5 mg pieces, and incubated in cell culture media for 24 hours